Effect of probucol treatment on malondialdehyde-modified low-density lipoproteins in type 2 diabetic patients with hypercholesterolemia.

被引：0
|
作者：
Iijima, H [1 ]
Sato, N [1 ]
Motohashi, S [1 ]
Kase, H [1 ]
Kawagoe, Y [1 ]
Matsumura, M [1 ]
Atsuta, H [1 ]
Enomoto, M [1 ]
Kato, T [1 ]
Mochizuki, Y [1 ]
Kanazawa, H [1 ]
Kuroda, H [1 ]
Bannba, N [1 ]
Hattori, Y [1 ]
Kasai, K [1 ]
机构：
[1] Dokkyo Univ, Sch Med, Dept Endocrinol & Metab, Mibu, Tochigi, Japan
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1229
引用
收藏
页码：A320 / A320
页数：1
相关论文
共 50 条
  • [1] MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH ATHEROSCLEROTIC DISEASE
    HOLVOET, P
    PEREZ, G
    ZHAO, Z
    BROUWERS, E
    BERNAR, H
    COLLEN, D
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06): : 2611 - 2619
  • [2] Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis
    Viigimaa, Margus
    Abina, Jelena
    Zemtsovskaya, Galina
    Tikhaze, Alla
    Konovalova, Galina
    Kumskova, Elena
    Lankin, Vadim
    BLOOD PRESSURE, 2010, 19 (03) : 164 - 168
  • [3] Role of atheroma liposomes and malondialdehyde-modified low-density lipoproteins in complement activation
    Sorace, JM
    Rollins, S
    Aniagolu, JA
    Mergner, WJ
    Cole, K
    Swartz, GM
    Green, SJ
    PATHOBIOLOGY, 1996, 64 (02) : 73 - 78
  • [4] SPECIFICITY OF RECEPTOR-MEDIATED RECOGNITION OF MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEINS
    HABERLAND, ME
    FOGELMAN, AM
    EDWARDS, PA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (06): : 1712 - 1716
  • [5] IMMUNOGENICITY OF MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEINS - STUDIES WITH MONOCLONAL-ANTIBODIES
    GONEN, B
    FALLON, JJ
    BAKER, SA
    ATHEROSCLEROSIS, 1987, 65 (03) : 265 - 272
  • [6] Improved method for the immunological detection of malondialdehyde-modified low-density lipoproteins in human serum
    Kitano, S
    Kanno, T
    Maekawa, M
    Sakurabayashi, I
    Kotani, K
    Hisatomi, H
    Hibi, N
    Kubono, K
    Harada, S
    ANALYTICA CHIMICA ACTA, 2004, 509 (02) : 229 - 235
  • [7] Metformin reduces circulating malondialdehyde-modified low-density lipoprotein in type 2 diabetes mellitus
    Ohira, Masahiro
    Yamaguchi, Takashi
    Saiki, Atsuhito
    Ban, Noriko
    Kawana, Hidetoshi
    Nagayama, Daiji
    Nagumo, Ayako
    Murano, Takeyoshi
    Shirai, Kohji
    Tatsuno, Ichiro
    CLINICAL AND INVESTIGATIVE MEDICINE, 2014, 37 (04): : E243 - E251
  • [8] Ezetimibe, an inhibitor of intestinal cholesterol absorption, decreases serum level of malondialdehyde-modified low-density lipoprotein in patients with hypercholesterolemia
    Ueda, Shin-ichiro
    Miyake, Ikuyo
    Takata, Kazuna
    Shimizu, Naomi
    Shirotani, Katsuro
    Ishida, Shiro
    Yonemitsu, Kazuaki
    Maeyama, Toyoaki
    Saito, Fumihiko
    Saito, Hiroyuki
    Yamagishi, Sho-ichi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 146 (03) : 420 - 421
  • [9] Increased incidence of coronary in-stent restenosis in type 2 diabetic patients is related to elevated serum malondialdehyde-modified low-density lipoprotein
    Shigematsu, Sakuji
    Takahashi, Naohiko
    Hara, Masahide
    Yoshimatsu, Hironobu
    Saikawa, Tetsunori
    CIRCULATION JOURNAL, 2007, 71 (11) : 1697 - 1702
  • [10] CHANGES OF APOLIPOPROTEIN-B MOLECULAR-WEIGHT AND IMMUNOREACTIVITY IN MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEINS
    BON, GB
    CAZZOLATO, G
    AVOGARO, P
    ARTERY, 1983, 12 (02) : 74 - 80
12345